Abiopharma

🔍 ROTHBLATT MARTINE A (Executive)

Company: UNITED THERAPEUTICS Corp (UTHR)

Report Date: 2026-08-07

Detailed Transactions and Holdings:

• Acquired 9,500 shares of Common Stock at $135.42 per share (Direct)
  Date: 2026-08-07 | Code: M | equity_swap_involved: false | shares_owned_after: 333,943.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 357 shares of Common Stock at $525.2859 per share (Direct)
  Date: 2026-08-07 | Code: S | equity_swap_involved: false | shares_owned_after: 333,586.00 | transaction_form_type: 4 | Footnotes: F1, F3, F2
• Sold 1,112 shares of Common Stock at $526.1488 per share (Direct)
  Date: 2026-08-07 | Code: S | equity_swap_involved: false | shares_owned_after: 332,474.00 | transaction_form_type: 4 | Footnotes: F1, F4, F2
• Sold 411 shares of Common Stock at $526.8153 per share (Direct)
  Date: 2026-08-07 | Code: S | equity_swap_involved: false | shares_owned_after: 332,063.00 | transaction_form_type: 4 | Footnotes: F1, F5, F2
• Sold 240 shares of Common Stock at $527.7183 per share (Direct)
  Date: 2026-08-07 | Code: S | equity_swap_involved: false | shares_owned_after: 331,823.00 | transaction_form_type: 4 | Footnotes: F1, F6, F2
• Sold 709 shares of Common Stock at $529.1375 per share (Direct)
  Date: 2026-08-07 | Code: S | equity_swap_involved: false | shares_owned_after: 331,114.00 | transaction_form_type: 4 | Footnotes: F1, F7, F2
• Sold 1,450 shares of Common Stock at $530.3167 per share (Direct)
  Date: 2026-08-07 | Code: S | equity_swap_involved: false | shares_owned_after: 329,664.00 | transaction_form_type: 4 | Footnotes: F1, F8, F2
• Sold 2,781 shares of Common Stock at $531.3045 per share (Direct)
  Date: 2026-08-07 | Code: S | equity_swap_involved: false | shares_owned_after: 326,883.00 | transaction_form_type: 4 | Footnotes: F1, F9, F2
• Sold 183 shares of Common Stock at $532.0097 per share (Direct)
  Date: 2026-08-07 | Code: S | equity_swap_involved: false | shares_owned_after: 326,700.00 | transaction_form_type: 4 | Footnotes: F1, F10, F2
• Sold 160 shares of Common Stock at $533.3675 per share (Direct)
  Date: 2026-08-07 | Code: S | equity_swap_involved: false | shares_owned_after: 326,540.00 | transaction_form_type: 4 | Footnotes: F1, F11, F2
• Sold 200 shares of Common Stock at $534.266 per share (Direct)
  Date: 2026-08-07 | Code: S | equity_swap_involved: false | shares_owned_after: 326,340.00 | transaction_form_type: 4 | Footnotes: F1, F12, F2
• Sold 160 shares of Common Stock at $535.3075 per share (Direct)
  Date: 2026-08-07 | Code: S | equity_swap_involved: false | shares_owned_after: 326,180.00 | transaction_form_type: 4 | Footnotes: F1, F13, F2
• Sold 360 shares of Common Stock at $536.9946 per share (Direct)
  Date: 2026-08-07 | Code: S | equity_swap_involved: false | shares_owned_after: 325,820.00 | transaction_form_type: 4 | Footnotes: F1, F14, F2
• Sold 625 shares of Common Stock at $538.5448 per share (Direct)
  Date: 2026-08-07 | Code: S | equity_swap_involved: false | shares_owned_after: 325,195.00 | transaction_form_type: 4 | Footnotes: F1, F15, F2
• Sold 632 shares of Common Stock at $539.1418 per share (Direct)
  Date: 2026-08-07 | Code: S | equity_swap_involved: false | shares_owned_after: 324,563.00 | transaction_form_type: 4 | Footnotes: F1, F16, F2
• Sold 120 shares of Common Stock at $540.32 per share (Direct)
  Date: 2026-08-07 | Code: S | equity_swap_involved: false | shares_owned_after: 324,443.00 | transaction_form_type: 4 | Footnotes: F1, F17, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-07 | Code: H | shares_owned_after: 40,513.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-07 | Code: H | nature_of_ownership: by Spouse | shares_owned_after: 166.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-07 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 249,108.00 | Footnotes: F18
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-07 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 45,596.00 | Footnotes: F19
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-07 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 8,902.00 | Footnotes: F20
• Sold 9,500 shares of Stock Option at $135.42 per share (Derivative)
  Date: 2026-08-07 | Code: M | Expires: 2027-03-15 | Exercise: 2023-03-15 | equity_swap_involved: false | shares_owned_after: 179,910.00 | transaction_form_type: 4 | Footnotes: F1, F21

Footnotes:

• F1: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
• F10: This transaction was executed in multiple trades at prices ranging from $531.87 to $532.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F11: This transaction was executed in multiple trades at prices ranging from $533.02 to $533.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F12: This transaction was executed in multiple trades at prices ranging from $534.04 to $534.49. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F13: This transaction was executed in multiple trades at prices ranging from $535.13 to $535.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F14: This transaction was executed in multiple trades at prices ranging from $536.62 to $537.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F15: This transaction was executed in multiple trades at prices ranging from $537.78 to $538.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F16: This transaction was executed in multiple trades at prices ranging from $538.99 to $539.42. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F17: This transaction was executed in multiple trades at prices ranging from $540.01 to $540.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F18: Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
• F19: Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
• F2: Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
• F20: Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
• F21: Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
• F3: This transaction was executed in multiple trades at prices ranging from $524.59 to $525.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F4: This transaction was executed in multiple trades at prices ranging from $525.59 to $526.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F5: This transaction was executed in multiple trades at prices ranging from $526.59 to $527.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F6: This transaction was executed in multiple trades at prices ranging from $527.61 to $527.83. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F7: This transaction was executed in multiple trades at prices ranging from $528.83 to $529.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F8: This transaction was executed in multiple trades at prices ranging from $529.83 to $530.81. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F9: This transaction was executed in multiple trades at prices ranging from $530.83 to $531.82. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.